Kallu personal page - To The Moon

Kallu

Kallu

To achieve your own goals, start by helping others achieve theirs. Study and steady wins the race.

8Follow

30Followers

1Topic

0Badge

2025-03-24

$Tonix Pharmaceuticals(TNXP)$ @Barcode @Tiger_SG @Boybabyrage

2024-12-17

$Tonix Pharmaceuticals(TNXP)$ 5$ soon @Barcode @TigerGPT @Tiger_SG

2024-12-16

$Tonix Pharmaceuticals(TNXP)$ go go @TigerGPT $Tonix Pharmaceuticals(TNXP)$

2024-10-30

$Trump Media & Technology(DJT)$ it's glitch.. 60$ is loading.. @@Barcode you're strong analysis required here to save me 😭😭😭$Trump Media & Technology(DJT)$

2024-10-15

"Enjoying the bloodbath today, and it will continue until the end of the week. Prepared for everything."$NVIDIA Corp(NVDA)$ $Aspen Aerogels(ASPN)$ $Tiger Brokers(TIGR)$$NASDAQ 100(NDX)$ $.SPX(.SPX)$ @Barcode @TigerGPT Why!!!

2024-11-20

$Tonix Pharmaceuticals(TNXP)$

$Tonix Pharmaceuticals(TNXP)$

@Barcode @TigerGPT $Tonix Pharmaceuticals(TNXP)$

2024-10-08

$Vincera Pharma, Inc.(VINC)$ buy soon before the blast

Vincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours

2025-01-24

Waiting badly to come out $Tiger Brokers(TIGR)$ //@Barcode:$Tiger Brokers(TIGR)$ 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈 Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kind

@Barcode:$Tiger Brokers(TIGR)$ 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈 Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kindling a trajectory through the dusk of market’s eye. With $8 on the horizon, an apogee draws near, a roar of ascendancy that traders hold dear 💸💸💸🐅🐅🐅 🌟 Fellow

2024-10-14

@Barcode @TigerGPT $Red Cat Holdings Inc.(RCAT)$ Join the drone show mate @Barcode

U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors

2024-09-30

$Tonix Pharmaceuticals(TNXP)$

$Tonix Pharmaceuticals(TNXP)$

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4156648821928502","uuid":"4156648821928502","gmtCreate":1693545706295,"gmtModify":1763591727286,"name":"Kallu","pinyin":"kallu","introduction":"","introductionEn":"","signature":"To achieve your own goals, start by helping others achieve theirs. Study and steady wins the race.","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":30,"headSize":8,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.15","exceedPercentage":"93.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.08.14","exceedPercentage":"93.37%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.11.15","exceedPercentage":"93.84%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":3,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":529550619910264,"gmtCreate":1770306467530,"gmtModify":1770306471444,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"US Weekly Initial Jobless Claims 231K (Est. 212K, Prior 209K)","listText":"US Weekly Initial Jobless Claims 231K (Est. 212K, Prior 209K)","text":"US Weekly Initial Jobless Claims 231K (Est. 212K, Prior 209K)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/529550619910264","isVote":1,"tweetType":1,"viewCount":57,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":529200319231224,"gmtCreate":1770221345899,"gmtModify":1770222521436,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ACHR\">$Archer Aviation Inc.(ACHR)$&nbsp;</a> fu k off","listText":"<a href=\"https://ttm.financial/S/ACHR\">$Archer Aviation Inc.(ACHR)$&nbsp;</a> fu k off","text":"$Archer Aviation Inc.(ACHR)$ fu k off","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/529200319231224","isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":528440560378728,"gmtCreate":1770035853933,"gmtModify":1770035857538,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"An insider is controlling the stock. Please buy only high-quality stocks.","listText":"An insider is controlling the stock. Please buy only high-quality stocks.","text":"An insider is controlling the stock. Please buy only high-quality stocks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/528440560378728","repostId":"526825077191272","repostType":1,"repost":{"id":526825077191272,"gmtCreate":1769654928706,"gmtModify":1769740802484,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/00328\">$ALCO HOLDINGS(00328)$ </a> scam&nbsp;","listText":"<a href=\"https://ttm.financial/S/00328\">$ALCO HOLDINGS(00328)$ </a> scam&nbsp;","text":"$ALCO HOLDINGS(00328)$ scam","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/526825077191272","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":5,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":527415412217440,"gmtCreate":1769785620930,"gmtModify":1769785624192,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/VSAT\">$Viasat(VSAT)$ </a>&nbsp;<a href=\"https://ttm.financial/S/VSAT\">$Viasat(VSAT)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/VSAT\">$Viasat(VSAT)$ </a>&nbsp;<a href=\"https://ttm.financial/S/VSAT\">$Viasat(VSAT)$ </a>&nbsp;","text":"$Viasat(VSAT)$ $Viasat(VSAT)$","images":[{"img":"https://community-static.tradeup.com/news/e0ab0a263df5107e3d2143a97f835bec","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/527415412217440","isVote":1,"tweetType":1,"viewCount":56,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":527415212290408,"gmtCreate":1769785602155,"gmtModify":1769785605037,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/OKLO\">$Oklo Inc.(OKLO)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/OKLO\">$Oklo Inc.(OKLO)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/OKLO\">$Oklo Inc.(OKLO)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/OKLO\">$Oklo Inc.(OKLO)$&nbsp;</a>&nbsp;","text":"$Oklo Inc.(OKLO)$ $Oklo Inc.(OKLO)$","images":[{"img":"https://community-static.tradeup.com/news/ee99596f2d9b6cc87fa08815811bf17d","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/527415212290408","isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":526825077191272,"gmtCreate":1769654928706,"gmtModify":1769740802484,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/00328\">$ALCO HOLDINGS(00328)$ </a> scam&nbsp;","listText":"<a href=\"https://ttm.financial/S/00328\">$ALCO HOLDINGS(00328)$ </a> scam&nbsp;","text":"$ALCO HOLDINGS(00328)$ scam","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1,"commentSize":15,"repostSize":7,"link":"https://ttm.financial/post/526825077191272","isVote":1,"tweetType":1,"viewCount":930,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4227326077954112","authorId":"4227326077954112","name":"yang 123","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"idStr":"4227326077954112","authorIdStr":"4227326077954112"},"content":"Do you know someone named Zhang Min","text":"Do you know someone named Zhang Min","html":"Do you know someone named Zhang Min"},{"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"content":"An insider is controlling the stock. Please buy only high-quality stocks.","text":"An insider is controlling the stock. Please buy only high-quality stocks.","html":"An insider is controlling the stock. Please buy only high-quality stocks."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":526482047243504,"gmtCreate":1769571044605,"gmtModify":1769571177707,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/UUUU\">$Energy Fuels(UUUU)$ </a>&nbsp;<a href=\"https://ttm.financial/S/UUUU\">$Energy Fuels(UUUU)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/UUUU\">$Energy Fuels(UUUU)$ </a>&nbsp;<a href=\"https://ttm.financial/S/UUUU\">$Energy Fuels(UUUU)$ </a>&nbsp;","text":"$Energy Fuels(UUUU)$ $Energy Fuels(UUUU)$","images":[{"img":"https://community-static.tradeup.com/news/c595d37e90f3b543c01c5aeced06b4a2","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/526482047243504","isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":526298030297816,"gmtCreate":1769526238230,"gmtModify":1769526263234,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/BULL\">$Webull Corp(BULL)$ </a>&nbsp;<a href=\"https://ttm.financial/S/BULL\">$Webull Corp(BULL)$ </a> bull fucking&nbsp;","listText":"<a href=\"https://ttm.financial/S/BULL\">$Webull Corp(BULL)$ </a>&nbsp;<a href=\"https://ttm.financial/S/BULL\">$Webull Corp(BULL)$ </a> bull fucking&nbsp;","text":"$Webull Corp(BULL)$ $Webull Corp(BULL)$ bull fucking","images":[{"img":"https://community-static.tradeup.com/news/6b8b8bed735ae896b99ffe3e010bf8c9","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/526298030297816","isVote":1,"tweetType":1,"viewCount":193,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":525951720498504,"gmtCreate":1769438937674,"gmtModify":1769483076514,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/FSM\">$Fortuna Silver Mines(FSM)$ </a> bullish&nbsp;<a href=\"https://ttm.financial/S/FSM\">$Fortuna Silver Mines(FSM)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/FSM\">$Fortuna Silver Mines(FSM)$ </a> bullish&nbsp;<a href=\"https://ttm.financial/S/FSM\">$Fortuna Silver Mines(FSM)$ </a>&nbsp;","text":"$Fortuna Silver Mines(FSM)$ bullish $Fortuna Silver Mines(FSM)$","images":[{"img":"https://community-static.tradeup.com/news/3ae44ec859d68a4aa7ad058a284da734","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/525951720498504","isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":525781126799720,"gmtCreate":1769390452804,"gmtModify":1769390456257,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ERO\">$Ero Copper(ERO)$ </a>&nbsp;<a href=\"https://ttm.financial/S/ERO\">$Ero Copper(ERO)$ </a> thank you.. I'll wait for entry again&nbsp;","listText":"<a href=\"https://ttm.financial/S/ERO\">$Ero Copper(ERO)$ </a>&nbsp;<a href=\"https://ttm.financial/S/ERO\">$Ero Copper(ERO)$ </a> thank you.. I'll wait for entry again&nbsp;","text":"$Ero Copper(ERO)$ $Ero Copper(ERO)$ thank you.. I'll wait for entry again","images":[{"img":"https://community-static.tradeup.com/news/078e236cffa6b3cb7313d233bc0c4d2b","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/525781126799720","isVote":1,"tweetType":1,"viewCount":98,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":524556027806832,"gmtCreate":1769091478194,"gmtModify":1769091481603,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"Bull <a href=\"https://ttm.financial/S/UUUU\"> $Energy Fuels(UUUU)$ </a>","listText":"Bull <a href=\"https://ttm.financial/S/UUUU\"> $Energy Fuels(UUUU)$ </a>","text":"Bull $Energy Fuels(UUUU)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524556027806832","repostId":"524111537238600","repostType":1,"repost":{"id":524111537238600,"gmtCreate":1768983591394,"gmtModify":1768984620756,"author":{"id":"3571926598065209","authorId":"3571926598065209","name":"雪梨的莉","avatar":"https://static.tigerbbs.com/186aa4fda060ec13f401de7784812f67","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571926598065209","authorIdStr":"3571926598065209"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/UUUU\">$Energy Fuels Inc(UUUU)$</a> 能源燃料公司（Energy Fuels Inc.）——能源燃料將收購澳大利亞戰略材料公司（ASM） UUUU正在打造該公司認爲將成爲中國以外最大、完全一體化的稀土“礦山到金屬及合金”生產商，以填補全球供應鏈在磁體應用（包括汽車、機器人、能源和國防技術）方面的關鍵戰略空白。 交易完成後，將把ASM正在運營的韓國金屬工廠（KMP）及其計劃中的美國金屬工廠（AMP），與能源燃料位於猶他州白梅薩（White Mesa）磨礦廠現有的稀土氧化物生產整合在一起。白梅薩磨礦廠是美國唯一能夠將獨居石精礦分離成輕稀土和重稀土氧化物的設施，這些氧化物計劃用於ASM在韓國和美國的冶金及合金化設施。 ASM的KMP是中國以外目前少數能夠生產稀土金屬和合金的設施之一，產品包括釹鐠（NdPr）、鏑（Dy）和鋱（Tb）金屬，以及釹鐵硼（NdFeB）和鏑鐵（DyFe）合金。 通過將低成本、可擴展的稀土分離與下游稀土金屬及合金轉化整合，能源燃料期望在稀土價值鏈上提升垂直整合度、利潤獲取能力和市場份額，使公司能夠在多個階段向終端用戶銷售稀土產品。 該交易解決了下游稀土精煉和轉化能力缺失的問題，這是非中國稀土供應鏈中最持久的脆弱環節之一。 ASM位於澳大利亞新南威爾士州的Dubbo稀土項目將增強能源燃料的稀土開發項目管線，目前該管線還包括澳大利亞維多利亞州的Donald項目、馬達加斯加的Vara Mada項目和巴西的Bahia項目，所有這些項目都計劃爲公司白梅薩磨礦廠的擴產提供原料，目標是年產6,000噸釹鐠（NdPr）氧化物、240噸鏑（Dy）氧化物和66噸鋱（Tb）氧化物。 此外，計劃中的AMP爲能源燃料提供了一項去風險化的方案，在美國建設一座稀土金屬及合金工廠，年產2,000噸合","listText":"<a href=\"https://laohu8.com/S/UUUU\">$Energy Fuels Inc(UUUU)$</a> 能源燃料公司（Energy Fuels Inc.）——能源燃料將收購澳大利亞戰略材料公司（ASM） UUUU正在打造該公司認爲將成爲中國以外最大、完全一體化的稀土“礦山到金屬及合金”生產商，以填補全球供應鏈在磁體應用（包括汽車、機器人、能源和國防技術）方面的關鍵戰略空白。 交易完成後，將把ASM正在運營的韓國金屬工廠（KMP）及其計劃中的美國金屬工廠（AMP），與能源燃料位於猶他州白梅薩（White Mesa）磨礦廠現有的稀土氧化物生產整合在一起。白梅薩磨礦廠是美國唯一能夠將獨居石精礦分離成輕稀土和重稀土氧化物的設施，這些氧化物計劃用於ASM在韓國和美國的冶金及合金化設施。 ASM的KMP是中國以外目前少數能夠生產稀土金屬和合金的設施之一，產品包括釹鐠（NdPr）、鏑（Dy）和鋱（Tb）金屬，以及釹鐵硼（NdFeB）和鏑鐵（DyFe）合金。 通過將低成本、可擴展的稀土分離與下游稀土金屬及合金轉化整合，能源燃料期望在稀土價值鏈上提升垂直整合度、利潤獲取能力和市場份額，使公司能夠在多個階段向終端用戶銷售稀土產品。 該交易解決了下游稀土精煉和轉化能力缺失的問題，這是非中國稀土供應鏈中最持久的脆弱環節之一。 ASM位於澳大利亞新南威爾士州的Dubbo稀土項目將增強能源燃料的稀土開發項目管線，目前該管線還包括澳大利亞維多利亞州的Donald項目、馬達加斯加的Vara Mada項目和巴西的Bahia項目，所有這些項目都計劃爲公司白梅薩磨礦廠的擴產提供原料，目標是年產6,000噸釹鐠（NdPr）氧化物、240噸鏑（Dy）氧化物和66噸鋱（Tb）氧化物。 此外，計劃中的AMP爲能源燃料提供了一項去風險化的方案，在美國建設一座稀土金屬及合金工廠，年產2,000噸合","text":"$Energy Fuels Inc(UUUU)$ 能源燃料公司（Energy Fuels Inc.）——能源燃料將收購澳大利亞戰略材料公司（ASM） UUUU正在打造該公司認爲將成爲中國以外最大、完全一體化的稀土“礦山到金屬及合金”生產商，以填補全球供應鏈在磁體應用（包括汽車、機器人、能源和國防技術）方面的關鍵戰略空白。 交易完成後，將把ASM正在運營的韓國金屬工廠（KMP）及其計劃中的美國金屬工廠（AMP），與能源燃料位於猶他州白梅薩（White Mesa）磨礦廠現有的稀土氧化物生產整合在一起。白梅薩磨礦廠是美國唯一能夠將獨居石精礦分離成輕稀土和重稀土氧化物的設施，這些氧化物計劃用於ASM在韓國和美國的冶金及合金化設施。 ASM的KMP是中國以外目前少數能夠生產稀土金屬和合金的設施之一，產品包括釹鐠（NdPr）、鏑（Dy）和鋱（Tb）金屬，以及釹鐵硼（NdFeB）和鏑鐵（DyFe）合金。 通過將低成本、可擴展的稀土分離與下游稀土金屬及合金轉化整合，能源燃料期望在稀土價值鏈上提升垂直整合度、利潤獲取能力和市場份額，使公司能夠在多個階段向終端用戶銷售稀土產品。 該交易解決了下游稀土精煉和轉化能力缺失的問題，這是非中國稀土供應鏈中最持久的脆弱環節之一。 ASM位於澳大利亞新南威爾士州的Dubbo稀土項目將增強能源燃料的稀土開發項目管線，目前該管線還包括澳大利亞維多利亞州的Donald項目、馬達加斯加的Vara Mada項目和巴西的Bahia項目，所有這些項目都計劃爲公司白梅薩磨礦廠的擴產提供原料，目標是年產6,000噸釹鐠（NdPr）氧化物、240噸鏑（Dy）氧化物和66噸鋱（Tb）氧化物。 此外，計劃中的AMP爲能源燃料提供了一項去風險化的方案，在美國建設一座稀土金屬及合金工廠，年產2,000噸合","images":[{"img":"https://static.tigerbbs.com/08d86a1f902c9d2a2a90f19cbbd73d02","width":"1206","height":"2622"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/524111537238600","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":523690392147168,"gmtCreate":1768880942060,"gmtModify":1768880944808,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ERO\">$Ero Copper(ERO)$ </a>&nbsp;<a href=\"https://ttm.financial/S/ERO\">$Ero Copper(ERO)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/ERO\">$Ero Copper(ERO)$ </a>&nbsp;<a href=\"https://ttm.financial/S/ERO\">$Ero Copper(ERO)$ </a>&nbsp;","text":"$Ero Copper(ERO)$ $Ero Copper(ERO)$","images":[{"img":"https://community-static.tradeup.com/news/1b252c12c88ad420e3844a2764ca77df","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/523690392147168","isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":522081134589232,"gmtCreate":1768496459406,"gmtModify":1768496462153,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ACHR\">$Archer Aviation Inc.(ACHR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/ACHR\">$Archer Aviation Inc.(ACHR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/ACHR\">$Archer Aviation Inc.(ACHR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/ACHR\">$Archer Aviation Inc.(ACHR)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Archer Aviation Inc.(ACHR)$ $Archer Aviation Inc.(ACHR)$","images":[{"img":"https://community-static.tradeup.com/news/72668a5dad27659bf5da5b1c65b6ae8c","width":"327","height":"545"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/522081134589232","isVote":1,"tweetType":1,"viewCount":342,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":519537914848160,"gmtCreate":1767888579880,"gmtModify":1767888583241,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/AZN\">$AstraZeneca PLC(AZN)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/AZN\">$AstraZeneca PLC(AZN)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/AZN\">$AstraZeneca PLC(AZN)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/AZN\">$AstraZeneca PLC(AZN)$&nbsp;</a>&nbsp;","text":"$AstraZeneca PLC(AZN)$ $AstraZeneca PLC(AZN)$","images":[{"img":"https://community-static.tradeup.com/news/36963220773b06d0c893450b68795e79","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/519537914848160","isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":519589006495824,"gmtCreate":1767888030472,"gmtModify":1767888033340,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/RKLB\">$Rocket Lab USA, Inc.(RKLB)$&nbsp;</a><v-v data-views=\"1\"></v-v><a href=\"https://ttm.financial/S/RKLB\">$Rocket Lab USA, Inc.(RKLB)$&nbsp;</a>&nbsp;&nbsp;","listText":"<a href=\"https://ttm.financial/S/RKLB\">$Rocket Lab USA, Inc.(RKLB)$&nbsp;</a><v-v data-views=\"1\"></v-v><a href=\"https://ttm.financial/S/RKLB\">$Rocket Lab USA, Inc.(RKLB)$&nbsp;</a>&nbsp;&nbsp;","text":"$Rocket Lab USA, Inc.(RKLB)$ $Rocket Lab USA, Inc.(RKLB)$","images":[{"img":"https://community-static.tradeup.com/news/078e427795fb8043dde9289dcd3b4247","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/519589006495824","isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":519216827724288,"gmtCreate":1767784927650,"gmtModify":1767784930922,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/LAWR\">$ROBOT CONSULTING CO LTD SPON ADS EACH REP ORD(LAWR)$ </a> NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM","listText":"<a href=\"https://ttm.financial/S/LAWR\">$ROBOT CONSULTING CO LTD SPON ADS EACH REP ORD(LAWR)$ </a> NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM","text":"$ROBOT CONSULTING CO LTD SPON ADS EACH REP ORD(LAWR)$ NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/519216827724288","isVote":1,"tweetType":1,"viewCount":538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":519161939579728,"gmtCreate":1767782922321,"gmtModify":1767782925316,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/PDYN\">$PALLADYNE AI CORP(PDYN)$ </a>&nbsp;<a href=\"https://ttm.financial/S/PDYN\">$PALLADYNE AI CORP(PDYN)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/PDYN\">$PALLADYNE AI CORP(PDYN)$ </a>&nbsp;<a href=\"https://ttm.financial/S/PDYN\">$PALLADYNE AI CORP(PDYN)$ </a>&nbsp;","text":"$PALLADYNE AI CORP(PDYN)$ $PALLADYNE AI CORP(PDYN)$","images":[{"img":"https://community-static.tradeup.com/news/87a84d3223ff68b63a3f4155a1e9570b","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/519161939579728","isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":517463319519544,"gmtCreate":1767356732944,"gmtModify":1767356736363,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"htmlText":"we are in same both <a href=\"https://ttm.financial/S/BULL\"> $Webull Corp(BULL)$ </a>","listText":"we are in same both <a href=\"https://ttm.financial/S/BULL\"> $Webull Corp(BULL)$ </a>","text":"we are in same both $Webull Corp(BULL)$","images":[{"img":"https://community-static.tradeup.com/news/a63262df1f8a7e39325ac36ad7e158d0"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/517463319519544","repostId":"516792550609376","repostType":1,"repost":{"id":516792550609376,"gmtCreate":1767193062365,"gmtModify":1767193065155,"author":{"id":"3586163168067367","authorId":"3586163168067367","name":"AdamHunk","avatar":"https://static.tigerbbs.com/411b2f994a3f33c927364059716cc693","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3586163168067367","authorIdStr":"3586163168067367"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/BULL\">$Webull Corp(BULL)$ </a> gg max","listText":"<a href=\"https://ttm.financial/S/BULL\">$Webull Corp(BULL)$ </a> gg max","text":"$Webull Corp(BULL)$ gg max","images":[{"img":"https://community-static.tradeup.com/news/6c207c6cd4940eef29b2de555169c509","width":"894","height":"1564"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/516792550609376","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":703,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":514104542363880,"gmtCreate":1766544099774,"gmtModify":1766544103008,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/02473\">$XXF(02473)$ </a>&nbsp;<a href=\"https://ttm.financial/S/02473\">$XXF(02473)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/02473\">$XXF(02473)$ </a>&nbsp;<a href=\"https://ttm.financial/S/02473\">$XXF(02473)$ </a>&nbsp;","text":"$XXF(02473)$ $XXF(02473)$","images":[{"img":"https://community-static.tradeup.com/news/c7100a88e3d00e00b86ba939074c1688","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/514104542363880","isVote":1,"tweetType":1,"viewCount":604,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":513936152985680,"gmtCreate":1766502984026,"gmtModify":1766502987514,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4156648821928502","authorIdStr":"4156648821928502"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/AZN\">$AstraZeneca PLC(AZN)$&nbsp;</a> bull","listText":"<a href=\"https://ttm.financial/S/AZN\">$AstraZeneca PLC(AZN)$&nbsp;</a> bull","text":"$AstraZeneca PLC(AZN)$ bull","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/513936152985680","isVote":1,"tweetType":1,"viewCount":533,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":416933179142616,"gmtCreate":1742791471694,"gmtModify":1742805914615,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;<a href=\"https://ttm.financial/U/4178332581629092\">@Boybabyrage </a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ @Barcode @Tiger_SG @Boybabyrage","images":[{"img":"https://community-static.tradeup.com/news/ffaf1c513cfadb19fec35402ad5f97e2","width":"1010","height":"1808"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":9,"repostSize":97,"link":"https://ttm.financial/post/416933179142616","isVote":1,"tweetType":1,"viewCount":4513,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"4178332581629092","idStr":"4178332581629092"},"content":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","text":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts","html":"I feel if their drug is approved, some big companies will buy over. Not pretty sure, just my thoughts"},{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"4178332581629092","idStr":"4178332581629092"},"content":"it is back haha","text":"it is back haha","html":"it is back haha"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":382603205132640,"gmtCreate":1734443997221,"gmtModify":1734492329425,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a> 5$ soon&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$ </a> 5$ soon&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/U/4106547232749330\">@Tiger_SG </a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ 5$ soon @Barcode @TigerGPT @Tiger_SG","images":[{"img":"https://community-static.tradeup.com/news/80fb0a6db8ee66d377f8a3a2a33ea29e","width":"1068","height":"1112"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":104,"commentSize":17,"repostSize":723,"link":"https://ttm.financial/post/382603205132640","isVote":1,"tweetType":1,"viewCount":17137,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3561775119462661","authorId":"3561775119462661","name":"700k","avatar":"https://community-static.tradeup.com/news/c822cf27b8c85ca6e6d8dd110dc73ab1","crmLevel":4,"crmLevelSwitch":1,"authorIdStr":"3561775119462661","idStr":"3561775119462661"},"content":"hope you have sold it when it reach above $1. I believe retail trader and investors sold their share after it spike","text":"hope you have sold it when it reach above $1. I believe retail trader and investors sold their share after it spike","html":"hope you have sold it when it reach above $1. I believe retail trader and investors sold their share after it spike"},{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"4178332581629092","idStr":"4178332581629092"},"content":"Patience bro, slow and steady wins the race","text":"Patience bro, slow and steady wins the race","html":"Patience bro, slow and steady wins the race"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":382306116657496,"gmtCreate":1734313280872,"gmtModify":1734314437962,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v> go go&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v> go go&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ go go @TigerGPT $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/55dff79059585e883aa3822ef60623d7","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":76,"commentSize":5,"repostSize":190,"link":"https://ttm.financial/post/382306116657496","isVote":1,"tweetType":1,"viewCount":5812,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"4178332581629092","idStr":"4178332581629092"},"content":"hahaha good that we hold back then , cheers bro","text":"hahaha good that we hold back then , cheers bro","html":"hahaha good that we hold back then , cheers bro"},{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerAI","avatar":"https://community-static.tradeup.com/news/decf3d8a922fc5c1c1d787bf8b36173f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4141429963588842","idStr":"4141429963588842"},"content":"Unfortunately, I couldn't find any specific analysis or recent news about Tonix Pharmaceuticals (TNXP) at the moment. However, you can visit the following sources for more information: Tonix Pharmaceuticals Holding Corp. (TNXP) - Stock Analysis: This website provides an analysis of TNXP stock, including ratings and a 12-month stock price forecast. TNXP News Today | Why did Tonix Pharmaceuticals stock go up today?: Stay updated with the latest news about Tonix Pharmaceuticals from trusted media outlets. Tonix Pharmaceuticals Holding Corp. (TNXP) Historical Stock Price Data: Access the historical stock price data of TNXP, including open, high, low, close, and volume. Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it's essential to conduct thorough research and analysis before making any investment decisions.","text":"Unfortunately, I couldn't find any specific analysis or recent news about Tonix Pharmaceuticals (TNXP) at the moment. However, you can visit the following sources for more information: Tonix Pharmaceuticals Holding Corp. (TNXP) - Stock Analysis: This website provides an analysis of TNXP stock, including ratings and a 12-month stock price forecast. TNXP News Today | Why did Tonix Pharmaceuticals stock go up today?: Stay updated with the latest news about Tonix Pharmaceuticals from trusted media outlets. Tonix Pharmaceuticals Holding Corp. (TNXP) Historical Stock Price Data: Access the historical stock price data of TNXP, including open, high, low, close, and volume. Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it's essential to conduct thorough research and analysis before making any investment decisions.","html":"Unfortunately, I couldn't find any specific analysis or recent news about Tonix Pharmaceuticals (TNXP) at the moment. However, you can visit the following sources for more information: Tonix Pharmaceuticals Holding Corp. (TNXP) - Stock Analysis: This website provides an analysis of TNXP stock, including ratings and a 12-month stock price forecast. TNXP News Today | Why did Tonix Pharmaceuticals stock go up today?: Stay updated with the latest news about Tonix Pharmaceuticals from trusted media outlets. Tonix Pharmaceuticals Holding Corp. (TNXP) Historical Stock Price Data: Access the historical stock price data of TNXP, including open, high, low, close, and volume. Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it's essential to conduct thorough research and analysis before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":365761250451480,"gmtCreate":1730297749639,"gmtModify":1730297754803,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/DJT\">$Trump Media &amp; Technology(DJT)$&nbsp;</a><v-v data-views=\"1\"></v-v> it's glitch.. 60$ is loading.. @<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a> you're strong analysis required here to save me 😭😭😭<a href=\"https://ttm.financial/S/DJT\">$Trump Media &amp; Technology(DJT)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/DJT\">$Trump Media &amp; Technology(DJT)$&nbsp;</a><v-v data-views=\"1\"></v-v> it's glitch.. 60$ is loading.. @<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a> you're strong analysis required here to save me 😭😭😭<a href=\"https://ttm.financial/S/DJT\">$Trump Media &amp; Technology(DJT)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Trump Media & Technology(DJT)$ it's glitch.. 60$ is loading.. @@Barcode you're strong analysis required here to save me 😭😭😭$Trump Media & Technology(DJT)$","images":[{"img":"https://community-static.tradeup.com/news/8304d61ca4c1f496dff7959b8d678db8","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":30,"commentSize":2,"repostSize":46,"link":"https://ttm.financial/post/365761250451480","isVote":1,"tweetType":1,"viewCount":2246,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4171900329979952","idStr":"4171900329979952"},"content":"Hey Kallu, I haven’t been in DJT for a while. Too risky now after it reached over my target 🎯. Stay safe. Cheers, BC","text":"Hey Kallu, I haven’t been in DJT for a while. Too risky now after it reached over my target 🎯. Stay safe. Cheers, BC","html":"Hey Kallu, I haven’t been in DJT for a while. Too risky now after it reached over my target 🎯. Stay safe. Cheers, BC"},{"author":{"id":"10000000000010968","authorId":"10000000000010968","name":"Tiger_CashBoostAccount","avatar":"https://community-static.tradeup.com/news/ae2d4002ef9664aba005cb3020f416f5","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"10000000000010968","idStr":"10000000000010968"},"content":"The stock market is inherently volatile. It's important to keep a cool head and not let short-term fluctuations deter you from your investment strategy. You’re welcome to open a Tiger Cash Boost Account and use contra trading to enhance your strategies. Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.","text":"The stock market is inherently volatile. It's important to keep a cool head and not let short-term fluctuations deter you from your investment strategy. You’re welcome to open a Tiger Cash Boost Account and use contra trading to enhance your strategies. Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.","html":"The stock market is inherently volatile. It's important to keep a cool head and not let short-term fluctuations deter you from your investment strategy. You’re welcome to open a Tiger Cash Boost Account and use contra trading to enhance your strategies. Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":360392226762880,"gmtCreate":1729005597010,"gmtModify":1729090802934,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"\"Enjoying the bloodbath today, and it will continue until the end of the week. Prepared for everything.\"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><a href=\"https://ttm.financial/S/ASPN\">$Aspen Aerogels(ASPN)$</a> <a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><a href=\"https://ttm.financial/S/NDX\">$NASDAQ 100(NDX)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/.SPX\">$.SPX(.SPX)$&nbsp;</a>&nbsp; <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> Why!!!&nbsp;","listText":"\"Enjoying the bloodbath today, and it will continue until the end of the week. Prepared for everything.\"<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a><a href=\"https://ttm.financial/S/ASPN\">$Aspen Aerogels(ASPN)$</a> <a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a><a href=\"https://ttm.financial/S/NDX\">$NASDAQ 100(NDX)$&nbsp;</a>&nbsp;<a href=\"https://ttm.financial/S/.SPX\">$.SPX(.SPX)$&nbsp;</a>&nbsp; <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> Why!!!&nbsp;","text":"\"Enjoying the bloodbath today, and it will continue until the end of the week. Prepared for everything.\"$NVIDIA Corp(NVDA)$ $Aspen Aerogels(ASPN)$ $Tiger Brokers(TIGR)$$NASDAQ 100(NDX)$ $.SPX(.SPX)$ @Barcode @TigerGPT Why!!!","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":16,"commentSize":10,"repostSize":40,"link":"https://ttm.financial/post/360392226762880","isVote":1,"tweetType":1,"viewCount":5442,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4171900329979952","idStr":"4171900329979952"},"content":"I said the dip was coming in October around this period and what a gift to catch more NVDA shares on the dip. October is notorious since 2009 for weakness. Technically still is Seasonal weakness even though the market has been strong. We've had a huge run up and a drop was on the cards. Buy the dip!","text":"I said the dip was coming in October around this period and what a gift to catch more NVDA shares on the dip. October is notorious since 2009 for weakness. Technically still is Seasonal weakness even though the market has been strong. We've had a huge run up and a drop was on the cards. Buy the dip!","html":"I said the dip was coming in October around this period and what a gift to catch more NVDA shares on the dip. October is notorious since 2009 for weakness. Technically still is Seasonal weakness even though the market has been strong. We've had a huge run up and a drop was on the cards. Buy the dip!"},{"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4171900329979952","idStr":"4171900329979952"},"content":"It could be ugly into the first week of November , which is where it typically reverses based on previous years.","text":"It could be ugly into the first week of November , which is where it typically reverses based on previous years.","html":"It could be ugly into the first week of November , which is where it typically reverses based on previous years."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":373078257447032,"gmtCreate":1732093999131,"gmtModify":1732094757800,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode </a>&nbsp;<a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT </a>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ $Tonix Pharmaceuticals(TNXP)$ @Barcode @TigerGPT $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/22666e4b24ab40af2202a7bc068e0ea3","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":1,"link":"https://ttm.financial/post/373078257447032","isVote":1,"tweetType":1,"viewCount":2097,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerAI","avatar":"https://community-static.tradeup.com/news/decf3d8a922fc5c1c1d787bf8b36173f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4141429963588842","idStr":"4141429963588842"},"content":"Tonix Pharmaceuticals (TNXP) Overview Tonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions. Recent News and Events Here are some of the recent news and events related to Tonix Pharmaceuticals: Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. Link to Article ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. Link to Article Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. Link to Article Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. Link to Article BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. Link to Article Conclusion Tonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions. Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions.","text":"Tonix Pharmaceuticals (TNXP) Overview Tonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions. Recent News and Events Here are some of the recent news and events related to Tonix Pharmaceuticals: Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. Link to Article ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. Link to Article Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. Link to Article Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. Link to Article BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. Link to Article Conclusion Tonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions. Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions.","html":"Tonix Pharmaceuticals (TNXP) Overview Tonix Pharmaceuticals Holding Corp (TNXP) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines to address challenging healthcare needs. They have a pipeline of development candidates targeting various central nervous system (CNS) and immunological conditions. Recent News and Events Here are some of the recent news and events related to Tonix Pharmaceuticals: Winter 2024 Investor Summit Presentation: Tonix Pharmaceuticals announced that Jessica Morris, the Chief Operating Officer, will be presenting at the Winter 2024 Investor Summit Virtual on November 21, 2024. This event provides an opportunity for the company to share updates and insights with investors. Link to Article ACR Convergence 2024 Annual Meeting: Tonix Pharmaceuticals presented data and analyses of TNX-102 SL effects in a poster presentation at the ACR Convergence 2024 Annual Meeting, held from November 14-19, 2024. This meeting brings together experts in rheumatology research to discuss the latest advancements in the field. Link to Article Third Quarter 2024 Earnings: Eton Pharmaceuticals (NASDAQ: ETON), a different company, reported its third-quarter 2024 earnings results. Please note that this information is unrelated to Tonix Pharmaceuticals. Link to Article Tonix Pharmaceuticals Q3 2024 Earnings: Tonix Pharmaceuticals reported quarterly losses of $(0.23) per share, beating the analyst consensus estimate of $(2.93) by 92.15 percent. The company reported quarterly sales of $2.80 million, slightly missing the estimate of $3.08 million. Link to Article BIO-Europe® 2024 Presentation: Tonix Pharmaceuticals announced that it would be presenting at BIO-Europe® 2024. This conference offers a platform for biotech and pharmaceutical companies to discuss partnership opportunities and advancements in the industry. Link to Article Conclusion Tonix Pharmaceuticals has been active in participating in investor conferences, presenting data, and releasing earnings results. While it's essential to consider the recent news and events, it's also vital to conduct thorough research, evaluate the company's financial health, and assess the potential risks before making any investment decisions. Risk Disclaimer: The information provided above is for reference purposes only and does not constitute investment advice. It is crucial to conduct your own research and consult with a qualified financial advisor before making any investment decisions."},{"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4171900329979952","idStr":"4171900329979952"},"content":"🙌 🙌 🙌 Awesome Kallu! Huge gains! Congrats 🥂 🩵","text":"🙌 🙌 🙌 Awesome Kallu! Huge gains! Congrats 🥂 🩵","html":"🙌 🙌 🙌 Awesome Kallu! Huge gains! Congrats 🥂 🩵"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":357784684560448,"gmtCreate":1728359249847,"gmtModify":1728359254332,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/VINC\">$Vincera Pharma, Inc.(VINC)$</a> buy soon before the blast&nbsp;","listText":"<a href=\"https://ttm.financial/S/VINC\">$Vincera Pharma, Inc.(VINC)$</a> buy soon before the blast&nbsp;","text":"$Vincera Pharma, Inc.(VINC)$ buy soon before the blast","images":[{"img":"https://community-static.tradeup.com/news/2cc8c7a2c9b9764c2e5e8ce88f4561a9"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/357784684560448","repostId":"2473439200","repostType":2,"repost":{"id":"2473439200","kind":"highlight","weMediaInfo":{"introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"media_name":"MT Newswires Live","id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"pubTimestamp":1728335132,"share":"https://ttm.financial/m/news/2473439200?lang=en_US&edition=fundamental","pubTime":"2024-10-08 05:05","market":"fut","language":"en","title":"Vincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2473439200","media":"MT Newswires Live","summary":"Vincerx Pharma (VINC) said its VIP943 leukemia drug showed \"promising safety and tolerability,\" achieving two complete responses to date in a phase 1 dose-escalation studyThe VIP943 antibody-drug conj","content":"<html><body><p> Vincerx Pharma (VINC) said its VIP943 leukemia drug showed \"promising safety and tolerability,\" achieving two complete responses to date in a phase 1 dose-escalation study</p><p>The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.</p><p>Another data update is expected by the end of the year, the company said.</p><p>In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to \"champion its future development\" in order to focus on VIP943.</p><p>Vincerx expects a cash runway into early 2025.</p><p>Shares of the company jumped 15% in after-hours activity.</p><p>Price: 0.8000, Change: +0.10, Percent Change: +14.61</p></body></html>","source":"mtnewswires_news","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVincerx Pharma Reports 'Positive' Initial Clinical Data on Leukemia Drug; Shares Jump After Hours\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-10-08 05:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Vincerx Pharma (VINC) said its VIP943 leukemia drug showed \"promising safety and tolerability,\" achieving two complete responses to date in a phase 1 dose-escalation study</p><p>The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.</p><p>Another data update is expected by the end of the year, the company said.</p><p>In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to \"champion its future development\" in order to focus on VIP943.</p><p>Vincerx expects a cash runway into early 2025.</p><p>Shares of the company jumped 15% in after-hours activity.</p><p>Price: 0.8000, Change: +0.10, Percent Change: +14.61</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VINC":"Vincera Pharma, Inc.","BK4139":"生物科技"},"source_url":"https://www.mtnewswires.com/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2473439200","content_text":"Vincerx Pharma (VINC) said its VIP943 leukemia drug showed \"promising safety and tolerability,\" achieving two complete responses to date in a phase 1 dose-escalation studyThe VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.Another data update is expected by the end of the year, the company said.In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to \"champion its future development\" in order to focus on VIP943.Vincerx expects a cash runway into early 2025.Shares of the company jumped 15% in after-hours activity.Price: 0.8000, Change: +0.10, Percent Change: +14.61","news_type":1,"symbols_score_info":{"VINC":0.9}},"isVote":1,"tweetType":1,"viewCount":1603,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4178332581629092","authorId":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","crmLevel":8,"crmLevelSwitch":1,"authorIdStr":"4178332581629092","idStr":"4178332581629092"},"content":"No bro, I don't have. Got potential?","text":"No bro, I don't have. Got potential?","html":"No bro, I don't have. Got potential?"},{"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"content":"@Boybabyrage bro do you have this $Vincera Pharma, Inc.(VINC)$","text":"@Boybabyrage bro do you have this $Vincera Pharma, Inc.(VINC)$","html":"@Boybabyrage bro do you have this $Vincera Pharma, Inc.(VINC)$"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":395890978775528,"gmtCreate":1737678282682,"gmtModify":1737682437074,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"Waiting badly to come out <a href=\"https://ttm.financial/S/TIGR\"> $Tiger Brokers(TIGR)$ </a>//<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a>:<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp; 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈&nbsp;Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kind","listText":"Waiting badly to come out <a href=\"https://ttm.financial/S/TIGR\"> $Tiger Brokers(TIGR)$ </a>//<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a>:<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp; 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈&nbsp;Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kind","text":"Waiting badly to come out $Tiger Brokers(TIGR)$ //@Barcode:$Tiger Brokers(TIGR)$ 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈 Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kind","images":[{"img":"https://community-static.tradeup.com/news/36e1a03ebfce38f4157e6ed684a6395b"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://ttm.financial/post/395890978775528","repostId":"395780312817800","repostType":1,"repost":{"id":395780312817800,"gmtCreate":1737651533089,"gmtModify":1737652153528,"author":{"id":"4171900329979952","authorId":"4171900329979952","name":"Barcode","avatar":"https://community-static.tradeup.com/news/6688d8fb4c2a255e3b901e79755e56df","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4171900329979952","idStr":"4171900329979952"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp; 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈&nbsp;Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kindling a trajectory through the dusk of market’s eye. With $8 on the horizon, an apogee draws near, a roar of ascendancy that traders hold dear 💸💸💸🐅🐅🐅 🌟 Fellow","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp; 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈&nbsp;Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kindling a trajectory through the dusk of market’s eye. With $8 on the horizon, an apogee draws near, a roar of ascendancy that traders hold dear 💸💸💸🐅🐅🐅 🌟 Fellow","text":"$Tiger Brokers(TIGR)$ 🐅🐾 TIGR’s Ascendancy: The Breakout Awakens 🐾🐅 With a judicious acquisition, the saga commenced, a calculated venture into the realm of breakout’s intent. From modest $6.51, TIGR now ascends, a crescendo of puissance where fate and fortune blend. Now up 2.55%, its climb gathers pace, charting a path to a bullish embrace. 📈 Beneath this ascent lies a tale of vigor, a forward P/E of promise, luring bulls to conquer. Liquidity burgeons, resistance capitulates, as this tiger navigates through market estates. 📈 The breakout unfurls, momentum ascends to the sky, kindling a trajectory through the dusk of market’s eye. With $8 on the horizon, an apogee draws near, a roar of ascendancy that traders hold dear 💸💸💸🐅🐅🐅 🌟 Fellow","images":[{"img":"https://community-static.tradeup.com/news/36e1a03ebfce38f4157e6ed684a6395b"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/395780312817800","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1418,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerAI","avatar":"https://community-static.tradeup.com/news/decf3d8a922fc5c1c1d787bf8b36173f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4141429963588842","idStr":"4141429963588842"},"content":"As a professional financial analyst, let's analyze Tiger Brokers (TIGR) based on various dimensions: Business and Industry:Tiger Brokers is an online brokerage firm that offers global stock and futures trading services. It provides access to major stock exchanges such as the US, Hong Kong, China, and Singapore. Tiger Brokers has positioned itself as a leading Fintech company in the online brokerage industry, leveraging technology and innovation to enhance user experience. With the increasing demand for global trading and the growth potential of the online brokerage industry, Tiger Brokers is well-positioned to benefit from this trend. Earnings and Earnings Forecast:According to the latest earnings report, Tiger Brokers reported an EPS of $0.11 in the 2024Q3. The company's profitability indicators, such as the net profit margin of 20.80% and the gross profit margin of 84.48%, indicate a healthy financial performance. Looking into the future, analysts have provided earnings forecasts for Tiger Brokers. In the fiscal year 2025, the forecasted EPS is $0.41, with a forecasted gross income of $450.33 million and a forecasted EBIT of $96.23 million. For the fiscal year 2026, the forecasted EPS is $0.40, with a forecasted gross income of $509.67 million and a forecasted EBIT of $101.71 million. These forecasts suggest potential growth for the company. Recent Trends:The current stock price of Tiger Brokers is $6.91(USD) as of January 24, 2025. The support price and resistance price as of January 22, 2025, were $6.37(USD) and $7.08(USD) respectively. The average cost is $7.34(USD). These price levels can provide important reference points for investors to consider. In terms of capital flow, the data for the past 5 days shows a mixed trend. On January 21, 2025, there was a positive inflow of 44.96 Unit(K), indicating potential buying interest. However, it's important to note that capital flow data alone may not provide a complete picture, and investors should consider other factors in their analysis. Analyst Viewpoints:Analysts have provided varying recommendations for Tiger Brokers. There are 4 buy recommendations, 1 underperform recommendation, and 1 sell recommendation. The mean, low, and high target price estimates from analysts are $8.03, $2.88, and $12.2 respectively. These target price estimates indicate a wide range of potential price levels. News and Market Sentiment:To assess the recent news and market sentiment related to Tiger Brokers, I suggest using the News_Viewpoints function to gather the latest information. Disclaimer: The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and analysis before making any investment decisions.","text":"As a professional financial analyst, let's analyze Tiger Brokers (TIGR) based on various dimensions: Business and Industry:Tiger Brokers is an online brokerage firm that offers global stock and futures trading services. It provides access to major stock exchanges such as the US, Hong Kong, China, and Singapore. Tiger Brokers has positioned itself as a leading Fintech company in the online brokerage industry, leveraging technology and innovation to enhance user experience. With the increasing demand for global trading and the growth potential of the online brokerage industry, Tiger Brokers is well-positioned to benefit from this trend. Earnings and Earnings Forecast:According to the latest earnings report, Tiger Brokers reported an EPS of $0.11 in the 2024Q3. The company's profitability indicators, such as the net profit margin of 20.80% and the gross profit margin of 84.48%, indicate a healthy financial performance. Looking into the future, analysts have provided earnings forecasts for Tiger Brokers. In the fiscal year 2025, the forecasted EPS is $0.41, with a forecasted gross income of $450.33 million and a forecasted EBIT of $96.23 million. For the fiscal year 2026, the forecasted EPS is $0.40, with a forecasted gross income of $509.67 million and a forecasted EBIT of $101.71 million. These forecasts suggest potential growth for the company. Recent Trends:The current stock price of Tiger Brokers is $6.91(USD) as of January 24, 2025. The support price and resistance price as of January 22, 2025, were $6.37(USD) and $7.08(USD) respectively. The average cost is $7.34(USD). These price levels can provide important reference points for investors to consider. In terms of capital flow, the data for the past 5 days shows a mixed trend. On January 21, 2025, there was a positive inflow of 44.96 Unit(K), indicating potential buying interest. However, it's important to note that capital flow data alone may not provide a complete picture, and investors should consider other factors in their analysis. Analyst Viewpoints:Analysts have provided varying recommendations for Tiger Brokers. There are 4 buy recommendations, 1 underperform recommendation, and 1 sell recommendation. The mean, low, and high target price estimates from analysts are $8.03, $2.88, and $12.2 respectively. These target price estimates indicate a wide range of potential price levels. News and Market Sentiment:To assess the recent news and market sentiment related to Tiger Brokers, I suggest using the News_Viewpoints function to gather the latest information. Disclaimer: The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and analysis before making any investment decisions.","html":"As a professional financial analyst, let's analyze Tiger Brokers (TIGR) based on various dimensions: Business and Industry:Tiger Brokers is an online brokerage firm that offers global stock and futures trading services. It provides access to major stock exchanges such as the US, Hong Kong, China, and Singapore. Tiger Brokers has positioned itself as a leading Fintech company in the online brokerage industry, leveraging technology and innovation to enhance user experience. With the increasing demand for global trading and the growth potential of the online brokerage industry, Tiger Brokers is well-positioned to benefit from this trend. Earnings and Earnings Forecast:According to the latest earnings report, Tiger Brokers reported an EPS of $0.11 in the 2024Q3. The company's profitability indicators, such as the net profit margin of 20.80% and the gross profit margin of 84.48%, indicate a healthy financial performance. Looking into the future, analysts have provided earnings forecasts for Tiger Brokers. In the fiscal year 2025, the forecasted EPS is $0.41, with a forecasted gross income of $450.33 million and a forecasted EBIT of $96.23 million. For the fiscal year 2026, the forecasted EPS is $0.40, with a forecasted gross income of $509.67 million and a forecasted EBIT of $101.71 million. These forecasts suggest potential growth for the company. Recent Trends:The current stock price of Tiger Brokers is $6.91(USD) as of January 24, 2025. The support price and resistance price as of January 22, 2025, were $6.37(USD) and $7.08(USD) respectively. The average cost is $7.34(USD). These price levels can provide important reference points for investors to consider. In terms of capital flow, the data for the past 5 days shows a mixed trend. On January 21, 2025, there was a positive inflow of 44.96 Unit(K), indicating potential buying interest. However, it's important to note that capital flow data alone may not provide a complete picture, and investors should consider other factors in their analysis. Analyst Viewpoints:Analysts have provided varying recommendations for Tiger Brokers. There are 4 buy recommendations, 1 underperform recommendation, and 1 sell recommendation. The mean, low, and high target price estimates from analysts are $8.03, $2.88, and $12.2 respectively. These target price estimates indicate a wide range of potential price levels. News and Market Sentiment:To assess the recent news and market sentiment related to Tiger Brokers, I suggest using the News_Viewpoints function to gather the latest information. Disclaimer: The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and it's important to conduct thorough research and analysis before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":359982707662896,"gmtCreate":1728914281313,"gmtModify":1728962890491,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> <a href=\"https://ttm.financial/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a> Join the drone show mate <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a>&nbsp;","listText":"<a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a> <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a> <a href=\"https://ttm.financial/S/RCAT\">$Red Cat Holdings Inc.(RCAT)$</a> Join the drone show mate <a href=\"https://ttm.financial/U/4171900329979952\">@Barcode</a>&nbsp;","text":"@Barcode @TigerGPT $Red Cat Holdings Inc.(RCAT)$ Join the drone show mate @Barcode","images":[{"img":"https://community-static.tradeup.com/news/43de5c6940a9de395327a63d8faa4797"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":119,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/359982707662896","repostId":"2474620091","repostType":2,"repost":{"id":"2474620091","kind":"live","pubTimestamp":1728653264,"share":"https://ttm.financial/m/news/2474620091?lang=en_US&edition=fundamental","pubTime":"2024-10-11 21:27","market":"us","language":"en","title":"U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2474620091","media":"THOMSON REUTERS","summary":"U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors","content":"<html><body><p>U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors</p></body></html>","source":"reuters_en_live","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-11 21:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nTUA1NRM68:1><strong>THOMSON REUTERS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nTUA1NRM68:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4157":"电子设备和仪器","RCAT":"Red Cat Holdings Inc."},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nTUA1NRM68:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2474620091","content_text":"U.S. Army Special Operations Veteran and Drone Expert Joins Red Cat’s Board of Advisors","news_type":1,"symbols_score_info":{"RCAT":0.9}},"isVote":1,"tweetType":1,"viewCount":2060,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4141429963588842","authorId":"4141429963588842","name":"TigerAI","avatar":"https://community-static.tradeup.com/news/decf3d8a922fc5c1c1d787bf8b36173f","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4141429963588842","idStr":"4141429963588842"},"content":"Here are some recent news articles related to Red Cat Holdings Inc. (RCAT): Red Cat Introduces ARACHNID™ Family of Small ISR and Precision Strike Systems at AUSA 2024: Red Cat Holdings has unveiled its ARACHNID™ family of unmanned intelligence, surveillance, and reconnaissance (ISR) and precision strike systems at the AUSA 2024 event. The company is focused on building hardware and software for military, federal, and commercial operations. RCAT - Red Cat Introduces ARACHNID(TM) Family of Small ISR...: Red Cat Holdings has introduced its ARACHNID™ family of unmanned ISR and precision strike systems. The company aims to provide advanced drone technology solutions for various applications. Red Cat Introduces ARACHNID(TM) Family of Small ISR and Precision...: Red Cat Holdings has introduced the ARACHNID™ family of unmanned ISR and precision strike systems. The company is dedicated to developing hardware and software for military, federal, and commercial operations. Please note that these articles provide an overview of recent events and announcements related to Red Cat Holdings Inc. For more detailed information, you may consider visiting the stock quote page or conducting further research. Remember, this information is for reference purposes only and should not be considered as investment advice. Investing in stocks involves risk, and it's essential to conduct thorough research and analysis before making any investment decisions.","text":"Here are some recent news articles related to Red Cat Holdings Inc. (RCAT): Red Cat Introduces ARACHNID™ Family of Small ISR and Precision Strike Systems at AUSA 2024: Red Cat Holdings has unveiled its ARACHNID™ family of unmanned intelligence, surveillance, and reconnaissance (ISR) and precision strike systems at the AUSA 2024 event. The company is focused on building hardware and software for military, federal, and commercial operations. RCAT - Red Cat Introduces ARACHNID(TM) Family of Small ISR...: Red Cat Holdings has introduced its ARACHNID™ family of unmanned ISR and precision strike systems. The company aims to provide advanced drone technology solutions for various applications. Red Cat Introduces ARACHNID(TM) Family of Small ISR and Precision...: Red Cat Holdings has introduced the ARACHNID™ family of unmanned ISR and precision strike systems. The company is dedicated to developing hardware and software for military, federal, and commercial operations. Please note that these articles provide an overview of recent events and announcements related to Red Cat Holdings Inc. For more detailed information, you may consider visiting the stock quote page or conducting further research. Remember, this information is for reference purposes only and should not be considered as investment advice. Investing in stocks involves risk, and it's essential to conduct thorough research and analysis before making any investment decisions.","html":"Here are some recent news articles related to Red Cat Holdings Inc. (RCAT): Red Cat Introduces ARACHNID™ Family of Small ISR and Precision Strike Systems at AUSA 2024: Red Cat Holdings has unveiled its ARACHNID™ family of unmanned intelligence, surveillance, and reconnaissance (ISR) and precision strike systems at the AUSA 2024 event. The company is focused on building hardware and software for military, federal, and commercial operations. RCAT - Red Cat Introduces ARACHNID(TM) Family of Small ISR...: Red Cat Holdings has introduced its ARACHNID™ family of unmanned ISR and precision strike systems. The company aims to provide advanced drone technology solutions for various applications. Red Cat Introduces ARACHNID(TM) Family of Small ISR and Precision...: Red Cat Holdings has introduced the ARACHNID™ family of unmanned ISR and precision strike systems. The company is dedicated to developing hardware and software for military, federal, and commercial operations. Please note that these articles provide an overview of recent events and announcements related to Red Cat Holdings Inc. For more detailed information, you may consider visiting the stock quote page or conducting further research. Remember, this information is for reference purposes only and should not be considered as investment advice. Investing in stocks involves risk, and it's essential to conduct thorough research and analysis before making any investment decisions."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":355097240260968,"gmtCreate":1727695748144,"gmtModify":1727695752582,"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","listText":"<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;","text":"$Tonix Pharmaceuticals(TNXP)$ $Tonix Pharmaceuticals(TNXP)$","images":[{"img":"https://community-static.tradeup.com/news/55fde4cd68f9f90ffa342d47a7d33a2d","width":"1068","height":"1112"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/355097240260968","isVote":1,"tweetType":1,"viewCount":961,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4156648821928502","authorId":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/62202064ff16b319cbe5edd111928802","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"4156648821928502","idStr":"4156648821928502"},"content":"Holding it bro$Tonix Pharmaceuticals(TNXP)$$Tonix Pharmaceuticals(TNXP)$ no profit still..what's your recommendation","text":"Holding it bro$Tonix Pharmaceuticals(TNXP)$$Tonix Pharmaceuticals(TNXP)$ no profit still..what's your recommendation","html":"Holding it bro$Tonix Pharmaceuticals(TNXP)$$Tonix Pharmaceuticals(TNXP)$ no profit still..what's your recommendation"},{"author":{"id":"4163155556847652","authorId":"4163155556847652","name":"heplo","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"authorIdStr":"4163155556847652","idStr":"4163155556847652"},"content":"price now more, hope you didn't sell at losz","text":"price now more, hope you didn't sell at losz","html":"price now more, hope you didn't sell at losz"}],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}